Combined Gabapentinoid and Opioid Use: The Consequences of Shifting Prescribing Trends
Douglas C. Throckmorton(United States Food and Drug Administration), Janet Woodcock(Center for Drug Evaluation and Research)
Cited by 14
Related Papers
Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling
|Clinical Pharmacology & Therapeutics|2007|582
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
|Nature Biotechnology|2010|406
The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
|Clinical Cancer Research|2005|220
PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products
|Kidney International|1995|174
Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gamma.
|The Journal of Experimental Medicine|1995|172